Bacterial co-infections and secondary infections and their antimicrobial resistance in Covid-19 patients during the second pandemic wave
GMS Hygiene and Infection Control · 05.03.2024 · 19 (Doc10) · Doc10
DOI: 10.3205/dgkh000465 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 05.03.2024. Verfasst von Ruchita Attal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Microbiology, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
COVID-19 pneumonia with an unusual outbreak is considered a new, global public health threat. Microbiological characterization of co-infections in patients with COVID-19 is important, and antimicrobial use is high. We aimed to describe microbiologically confirmed co-infections and the antimicrobial resistance of the causative pathogens.
Method
From January to December 2020, we tested 1,301 patients who were COVID-19 positive. We received clinical samples (blood, respiratory and sterile body fluids) of COVID-19 patients who were suspected to have bacterial co-infections. Samples were processed and antimicrobial susceptibility testing was performed based on the CLSI recommendation. Demographic, clinical, laboratory and outcome data of those with positive cultures were collected.
Result
A total of 1301 COVID-19 patients (568 from the COVID ward and 733 from ICU) were admitted to the Covid care ward of a tertiary care hospital. 363 samples were sent for culturing and testing antibiotic susceptibility, of which 131 (36%) were found to be culture-positive (90 from ICUs, 41 from wards). Out of the 143 total isolates thus obtained from 131 samples, the majority (62.2%) were Gram-negative bacteria, and most of them were (70.8%) multidrug resistant.
Discussion
Bacterial co-infection in patients with COVID-19 is more commonly reported in the severely ill hospitalized individuals (58%), particularly in the ICU (73.3%) setting. In terms of mortality, almost half of co-infected patients died (51.1%). In most of them, the cause of death was found to be sepsis with post-COVID ARDS (58%).
Conclusion
Co-infection in COVID-19 patients may affect the outcome in terms of increasing the hospital stay.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dept of Microbiology, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India.
Zitieren
APA
Attal, R., & Deotale, V. (2024). Bacterial co-infections and secondary infections and their antimicrobial resistance in Covid-19 patients during the second pandemic wave. GMS Hygiene and Infection Control, 19(Doc10), Doc10. https://doi.org/10.3205/dgkh000465
Vancouver
Attal R, Deotale V. Bacterial co-infections and secondary infections and their antimicrobial resistance in Covid-19 patients during the second pandemic wave. GMS Hygiene and Infection Control. 2024;19(Doc10):Doc10. doi:10.3205/dgkh000465
BibTeX
@article{Attal2024,
author = {Attal, Ruchita and Deotale, Vijayshri},
title = {Bacterial co-infections and secondary infections and their antimicrobial resistance in Covid-19 patients during the second pandemic wave},
journal = {GMS Hygiene and Infection Control},
year = {2024},
volume = {19},
number = {Doc10},
pages = {Doc10},
doi = {10.3205/dgkh000465}
}
EUVIMED